相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
Fabio Conforti et al.
LANCET ONCOLOGY (2018)
Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis
Xiaohui Wang et al.
ONCOTARGET (2017)
Anti-PD-1/PD-L1 antibody versus conventional chemotherapy for previously-treated, advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials
Yongxun Zhuansun et al.
JOURNAL OF THORACIC DISEASE (2017)
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
Jan Willem Kleinovink et al.
ONCOIMMUNOLOGY (2017)
Cancer immunotherapies targeting the PD-1 signaling pathway
Yoshiko Iwai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Plea for routinely presenting prediction intervals in meta-analysis
Joanna IntHout et al.
BMJ OPEN (2016)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
Lazaros Belbasis et al.
LANCET NEUROLOGY (2015)
Odds ratio vs risk ratio in randomized controlled trials
Haribalakrishna Balasubramanian et al.
POSTGRADUATE MEDICINE (2015)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi et al.
ONCOTARGET (2014)
Clarifications on the application and interpretation of the test for excess significance and its extensions
John P. A. Ioannidis
JOURNAL OF MATHEMATICAL PSYCHOLOGY (2013)
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK
Qi-Jing Wang et al.
Chinese Journal of Cancer (2012)
Excess Significance Bias in the Literature on Brain Volume Abnormalities
John P. A. Ioannidis
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma
Guanghui Gao et al.
ACTA ONCOLOGICA (2010)
Comment on: heterogeneity in meta-analysis should be expected and appropriately quantified
Michael D. Coory
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
A re-evaluation of random-effects meta-analysis
Julian P. T. Higgins et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2009)
GRADE:: what is quality of evidence and why is it important to clinicians?
Gordon H. Guyatt et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: A systematic review and meta-analysis
Holger Schulz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
An exploratory test for an excess of significant findings
John P. A. Ioannidis et al.
CLINICAL TRIALS (2007)
分享论文
